Dopamine is not an independent risk factor for reduced amikacin clearance in extremely low-birth-weight infants | Zendy

Karel Allegaert | Zendy; Anne Debeer | Zendy; Veerle Cossey | Zendy; Maissa Rayyan | Zendy; Hugo Devlieger | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dopamine is not an independent risk factor for reduced amikacin clearance in extremely low-birth-weight infants

Author(s) -

Karel Allegaert,

Anne Debeer,

Veerle Cossey,

Maissa Rayyan,

Hugo Devlieger

Publication year - 2006

Publication title -

pediatric critical care medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.299

H-Index - 87

eISSN - 1947-3893

pISSN - 1529-7535

DOI - 10.1097/01.pcc.0000200971.65255.f0

Subject(s) - medicine , amikacin , dopamine , risk factor , low birth weight , birth weight , pediatrics , pregnancy , antibiotics , genetics , microbiology and biotechnology , biology

Important inter-individual variability in amikacin clearance was observed in preterm infants, only in part explained by gestational age (GA), birth weight, or coadministration of nonselective cyclo-oxygenase (COX) inhibitor. We therefore evaluated whether dopamine had an additional effect on amikacin clearance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research